Skip to content
PubMed This is a summary of 53 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 53 referenced papers

Top Authors

Arnaud de la Fouchardière
Centre Léon Bérard
Shreyaskumar Patel
The University of Texas MD Anderson Cancer Center
John Hanna
Brigham and Women's Hospital
Jean‐Yves Blay
Université Claude Bernard Lyon 1
Silvia Stacchiotti
Fondazione IRCCS Istituto Nazionale dei Tumori
Cristina R. Antonescu
Memorial Sloan Kettering Cancer Center
Paolo G. Casali
University of Milan
George D. Demetri
Harvard University
Klaus J. Busam
Memorial Sloan Kettering Cancer Center

Top Institutions

Ranked by publications Top 10 institutions

References

References (53)
  1. 1

    Clear cell sarcoma of soft tissue in right parapharyngeal region: report of a rare case.

    Fan C, Yu J, Yang L, et al.

    International journal of clinical and experimental pathology 2015; (8(9)):10935-40.

    PMID: 26617810
  2. 2

    A giant clear cell sarcoma on right scapular: A case report.

    Zhang X, Hu C, Cai L

    Acta orthopaedica et traumatologica turcica 2016; (50(4)):473-6.

    PMID: 27452744
  3. 3

    Brain metastasis from gastrointestinal clear cell sarcoma.

    Guraya SS, Prayson RA

    Clinical neuropathology 2017; (36 (2017)(1)):41-45 doi:10.5414/NP300965.

    PMID: 27719746
  4. 4

    Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma.

    Ecker BL, Peters MG, McMillan MT, et al.

    Annals of surgical oncology 2017; (24(2)):425-433 doi:10.1245/s10434-016-5641-1.

    PMID: 27785659
  5. 5

    Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.

    Nakai T, Imura Y, Tamiya H, et al.

    Cancer medicine 2017; (6(9)):2121-2130 doi:10.1002/cam4.1130.

    PMID: 28745431
  6. 6

    Clear cell sarcoma of the scalp: A case report.

    Ogawa T, Maruyama H, Tanaka R, et al.

    The Journal of dermatology 2017; (44(11)):e276-e277 doi:10.1111/1346-8138.13979.

    PMID: 28791725
  7. 7

    Primary Clear Cell Sarcoma of the Dermis Mimicking Malignant Melanoma.

    Obiorah IE, Brenholz P, Özdemirli M

    Balkan medical journal 2018; (35(2)):203-207 doi:10.4274/balkanmedj.2017.0796.

    PMID: 29072181
  8. 8

    Morphology quiz: Cytology of a palmar swelling with axillary lymphadenopathy.

    Gupta P, Rajwanshi A

    Cytopathology : official journal of the British Society for Clinical Cytology 2018; (29(6)):592-594 doi:10.1111/cyt.12603.

    PMID: 29923360
  9. 9

    Clear cell sarcoma-A review.

    Ibrahim RM, Steenstrup Jensen S, Juel J

    Journal of orthopaedics 2018; (15(4)):963-966 doi:10.1016/j.jor.2018.08.039.

    PMID: 30210202
  10. 10

    Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.

    Segawa K, Sugita S, Aoyama T, et al.

    Diagnostic pathology 2018; (13(1)):73 doi:10.1186/s13000-018-0752-6.

    PMID: 30219084
  11. 11

    CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model.

    Kawashima K, Saigo C, Kito Y, et al.

    Oncology letters 2019; (17(6)):4811-4818 doi:10.3892/ol.2019.10164.

    PMID: 31186687
  12. 12

    Clear cell sarcoma in unusual sites mimicking metastatic melanoma.

    Obiorah IE, Ozdemirli M

    World journal of clinical oncology 2019; (10(5)):213-221 doi:10.5306/wjco.v10.i5.213.

    PMID: 31205866
  13. 13

    Prognostic Factors for Survival in Patients with Clear Cell Sarcoma: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.

    Li AB, Jiang BJ, Wang HH, et al.

    Medical science monitor : international medical journal of experimental and clinical research 2019; (25()):6950-6956 doi:10.12659/MSM.916705.

    PMID: 31522190
  14. 14

    A rare case of primary dermal clear cell sarcoma with focal epidermotropism: An entity difficult to distinguish from melanoma.

    Nawrocki S, Fitzhugh VA, Groisberg R, et al.

    Journal of cutaneous pathology 2020; (47(7)):621-624 doi:10.1111/cup.13659.

    PMID: 32012324
  15. 15

    Clear cell sarcoma of the esophagus: A rare location.

    Yahyaoui Y, Zenzri Y, Behi K, et al.

    Clinical case reports 2020; (8(2)):323-326 doi:10.1002/ccr3.2620.

    PMID: 32128181
  16. 16

    Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?

    Hirschmann A, van Praag VM, Haas RL, et al.

    European radiology 2020; (30(9)):4724-4733 doi:10.1007/s00330-020-06810-z.

    PMID: 32314057
  17. 17

    Analysis of prognostic factors in soft tissue sarcoma: Cancer registry from a single tertiary hospital in Indonesia. A retrospective cohort study.

    Mahyudin F, Edward M, Basuki MH, et al.

    Annals of medicine and surgery (2012) 2020; (57()):257-263 doi:10.1016/j.amsu.2020.07.053.

    PMID: 32884743
  18. 18

    Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.

    Basile G, Mattei JC, Alshaygy I, et al.

    Cancer 2020; (126(23)):5098-5108 doi:10.1002/cncr.33189.

    PMID: 32910462
  19. 19

    The value of re-staging chest CT at first local recurrence of extremity and trunk soft tissue sarcoma.

    Baig MS, Habib W, Attard V, et al.

    European radiology 2021; (31(4)):2377-2383 doi:10.1007/s00330-020-07366-8.

    PMID: 33037910
  20. 20

    Superficial Clear Cell Sarcoma (Melanoma of Soft Parts) of the Large toe in an 80-Year-Old Female With a Rare Cytogenetic Translocation.

    Zambrano R, Moesch J, Davis ER, et al.

    Cureus 2020; (12(11)):e11719 doi:10.7759/cureus.11719.

    PMID: 33391950
  21. 21

    FISH for EWSR1 in Ewing's sarcoma family of tumors: Experience from a tertiary care cancer center.

    Murthy SS, Gundimeda SD, Challa S, et al.

    Indian journal of pathology & microbiology 2021; (64(1)):96-101 doi:10.4103/IJPM.IJPM_267_20.

    PMID: 33433416
  22. 22

    Malignant gastrointestinal neuroectodermal tumor-A case report.

    Harshavardhini S, Saishalini CN, Pavithra V, et al.

    Indian journal of pathology & microbiology 2021; (64(2)):373-375 doi:10.4103/IJPM.IJPM_269_20.

    PMID: 33851638
  23. 23

    [Soft tissue clear cell sarcoma. A report of three cases].

    Bonatskaya AA, Minaeva AE, Vinogradov II

    Arkhiv patologii 2021; (83(3)):35-39 doi:10.17116/patol20218303135.

    PMID: 34041894
  24. 24

    Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing.

    Yao Q, Bai Q, Zhang X, et al.

    Archives of pathology & laboratory medicine 2022; (146(10)):1234-1242 doi:10.5858/arpa.2021-0230-OA.

    PMID: 35041745
  25. 25

    Trends of lymph node sampling and metastasis in pediatric and young adult patients with clear cell, epithelioid, and synovial sarcomas.

    Weller JH, Westermann C, Patel P, et al.

    Pediatric blood & cancer 2022; (69(6)):e29455 doi:10.1002/pbc.29455.

    PMID: 35466567
  26. 26

    Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network.

    Smrke A, Frezza AM, Giani C, et al.

    ESMO open 2022; (7(3)):100522 doi:10.1016/j.esmoop.2022.100522.

    PMID: 35717681
  27. 27

    Cutaneous Melanocytic Tumor With CRTC1::TRIM11 Translocation : An Emerging Entity Analyzed in a Series of 41 Cases.

    Hanna J, Ko JS, Billings SD, et al.

    The American journal of surgical pathology 2022; (46(11)):1457-1466 doi:10.1097/PAS.0000000000001952.

    PMID: 35993578
  28. 28

    Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma.

    Li BX, David LL, Davis LE, Xiao X

    The Journal of biological chemistry 2022; (298(10)):102434 doi:10.1016/j.jbc.2022.102434.

    PMID: 36041632
  29. 29

    Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy.

    Sidlik Muskatel R, Pillar N, Godefroy J, et al.

    Frontiers in pediatrics 2022; (10()):940927 doi:10.3389/fped.2022.940927.

    PMID: 36275056
  30. 30

    Multiple metastases of clear cell sarcoma at diagnosis presented in bone marrow aspirate: A case report.

    Li J, Jin Q, Shang Y, Yu P

    Diagnostic cytopathology 2023; (51(3)):E105-E108 doi:10.1002/dc.25091.

    PMID: 36533698
  31. 31

    Clear-Cell Sarcoma With an Unusual Presentation Mimicking Metastatic Melanoma.

    Tahiri Elousrouti L, Hammas N, Elmernissi FZ, et al.

    Cureus 2022; (14(11)):e32010 doi:10.7759/cureus.32010.

    PMID: 36589177
  32. 32

    Compound clear cell sarcoma with EWSR1::CREM fusion.

    Li P, Busam K

    Journal of cutaneous pathology 2023; (50(12)):1065-1069 doi:10.1111/cup.14390.

    PMID: 36640048
  33. 33

    Uncovering the gaps: A systematic mixed studies review of quality of life measures in extremity soft tissue sarcoma.

    Hassani M, Mate KKV, Turcotte R, et al.

    Journal of surgical oncology 2023; (128(3)):430-437 doi:10.1002/jso.27390.

    PMID: 37537979
  34. 34

    Systemic Therapy in Advanced Pleomorphic Liposarcoma: a Comprehensive Review.

    Assi T, Ngo C, Faron M, et al.

    Current treatment options in oncology 2023; (24(11)):1598-1613 doi:10.1007/s11864-023-01139-3.

    PMID: 37843627
  35. 35

    Factors associated with survival in patients with clear cell sarcoma.

    Fujiwara T, Kunisada T, Nakata E, et al.

    The bone & joint journal 2023; (105-B(11)):1216-1225 doi:10.1302/0301-620X.105B11.BJJ-2022-0743.R3.

    PMID: 37907082
  36. 36

    A Clear Cell Sarcoma Case: A Diagnostic and Treatment Challenge, with a Promising Response to Trabectedin.

    Galera M, Álvarez R, Arregui M, et al.

    Case reports in oncology 2023; (16(1)):1542-1550 doi:10.1159/000534935.

    PMID: 38074516
  37. 37

    Enhancing local recurrence detection in patients with high-grade soft tissue sarcoma: value of short-term Ultrasonography added to post-operative MRI surveillance.

    Park HY, Chung HW, Yoon MA, et al.

    Cancer imaging : the official publication of the International Cancer Imaging Society 2024; (24(1)):12 doi:10.1186/s40644-023-00645-9.

    PMID: 38243293
  38. 38

    Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma.

    Guadagnolo BA, Baldini EH

    Seminars in radiation oncology 2024; (34(2)):180-194 doi:10.1016/j.semradonc.2023.12.003.

    PMID: 38508783
  39. 39

    Navigating diagnostic challenges-distinguishing malignant melanoma and clear cell sarcoma of soft tissues: a case report and review of the literature.

    Abdouh S, Boujguenna I, Soleh A, et al.

    Journal of medical case reports 2024; (18(1)):249 doi:10.1186/s13256-024-04542-y.

    PMID: 38755643
  40. 40

    Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy.

    Czarnecka AM, Chmiel P, Błoński PJ, et al.

    Journal of chemotherapy (Florence, Italy) 2025; (37(4)):341-352 doi:10.1080/1120009X.2024.2372524.

    PMID: 38973299
  41. 41

    Metastatic clear cell sarcoma of the pancreas: A sporadic cancer.

    Gebbia V, Carnaghi C

    World journal of clinical cases 2024; (12(18)):3291-3294 doi:10.12998/wjcc.v12.i18.3291.

    PMID: 38983428
  42. 42

    Contemporary surgical management of pediatric non-rhabdomyosarcoma soft tissue sarcoma.

    Polites SF, Rhee DS, Seitz G, et al.

    Pediatric blood & cancer 2024; (71(11)):e31257 doi:10.1002/pbc.31257.

    PMID: 39138613
  43. 43

    Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy.

    Li S, Sun Q, Bai R, et al.

    BMC cancer 2024; (24(1)):1028 doi:10.1186/s12885-024-12810-9.

    PMID: 39164643
  44. 44

    Clear cell sarcoma in Japan: an analysis of the population-based cancer registry in Japan.

    Takemori T, Ogura K, Morizane C, et al.

    Japanese journal of clinical oncology 2024; (54(12)):1281-1287 doi:10.1093/jjco/hyae112.

    PMID: 39196756
  45. 45

    Metastatic clear cell sarcoma of the pancreas: An overview.

    Ait Addi R

    World journal of clinical cases 2024; (12(29)):6262-6265 doi:10.12998/wjcc.v12.i29.6262.

    PMID: 39417060
  46. 46

    Clear Cell Sarcoma of the Soft Tissue in the Distal Phalanx of the Great Toe: A Case Report.

    Park H, Kang WY, Woo OH, Kim A

    Journal of the Korean Society of Radiology 2024; (85(6)):1189-1193 doi:10.3348/jksr.2024.0083.

    PMID: 39660322
  47. 47

    Primary intraretinal clear cell sarcoma presenting as an amelanotic circumpapillary tumor.

    Steinkerchner MS, Mukai S, Stagner AM

    American journal of ophthalmology case reports 2025; (37()):102251 doi:10.1016/j.ajoc.2025.102251.

    PMID: 39895874
  48. 48

    Clear Cell Sarcoma (CCS) of the Soft Tissue: An Update Narrative Review with Emphasis on the Utility of PRAME in Differential Diagnosis.

    Cazzato G, Piscazzi F, Filosa A, et al.

    Journal of clinical medicine 2025; (14(4)) doi:10.3390/jcm14041233.

    PMID: 40004764
  49. 49

    The implications of abnormal signal patterns of break-apart FISH probes used in the diagnosis of bone and soft tissue tumours.

    Ye H, Berisha F, Rowles E, et al.

    Pathology oncology research : POR 2025; (31()):1612142 doi:10.3389/pore.2025.1612142.

    PMID: 40666501
  50. 50

    Ultrasound Versus Magnetic Resonance Imaging for Extremity Soft Tissue Sarcoma Surveillance: A Scoping Review.

    Smith J, Dallas-Orr D, Todi N, et al.

    Journal of surgical oncology 2025; (132(6)):1149-1154 doi:10.1002/jso.70079.

    PMID: 40900433
  51. 51

    Clear cell sarcoma : a retrospective review from a tertiary orthopaedic sarcoma unit.

    Green N, Archer JE, Baird CAE, Evans S

    The bone & joint journal 2026; (108-B(2)):234-240 doi:10.1302/0301-620X.108B2.BJJ-2025-0526.R1.

    PMID: 41619781
  52. 52

    [Cutaneous clear cell sarcoma].

    Vallejo A

    Pathologie (Heidelberg, Germany) 2026; doi:10.1007/s00292-026-01574-7.

    PMID: 42307723
  53. 53

    VEBrant: a multicenter, phase II study of MET inhibitor vebreltinib combined with PD-1-based immunotherapy in advanced clear cell sarcoma.

    Jiang Y, Lin N, Huang X, et al.

    Future oncology (London, England) 2026; 1-7 doi:10.1080/14796694.2026.2695212.

    PMID: 42376809